[Chemotherapy for advanced non-small-cell lung cancer. From the exclusive use of "P" to a quantitative probabilistic interpretation of meta-analytic data].
Pappagallo
Giovanni L
GL
Ufficio di Epidemiologia e Sperimentazioni Cliniche, Dipartimento di Oncologia ed Ematologia Oncologica, Ospedale PF Calvi, Noale, VE.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002945:Cisplatin / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D015201:Meta-Analysis as Topic; D013223:Statistics as Topic / Q000379:methods*; D016896:Treatment Outcome; D000093542:Gemcitabine
D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine